The National Coalition for LGBTQ Health has launched the “mfax” education and awareness campaign to raise awareness and provide education about mpox prevention, vaccination, testing, and treatment, as well as foster LGBTQ community engagement.
Two vaccines can be used to prevent mpox: JYNNEOS® and ACAM2000®, but only JYNNEOS has been used in the ongoing clade II outbreak. Healthcare providers should evaluate and counsel patients who could benefit from mpox vaccination by performing a social and sexual history.
Archived update from the White House from December 2024. During the 2022 global outbreak of clade II mpox, the Biden-Harris Administration mounted a robust response by making vaccines, tests, and treatment available to those at risk in the United States and abroad.
These downloadable fact sheets from the CDC answer common questions about safer sex, social gatherings, and mpox.
Demetre Daskalakis, MD, MPH, Acting Director of the National Center for Immunization and Respiratory Diseases at the CDC, provides the latest on mpox in this FAQ series from KFF and CDC.
To help meet domestic and international mpox response goals, CDC is urging clinicians to let patients with mpox know that oral tecovirimat is available through STOMP and encourage them to enroll. Providers should inform patients about STOMP so they can consider enrolling in the study.
This resource page from the CDC provides examples and best practices for slowing the spread of mpox.
These case definitions from the CDC enable public health officials to classify and count mpox cases consistently across reporting jurisdictions.
This fact sheet for clinicians provides information on identifying, controlling, and preventing mpox.
This information page from the CDC provides a checklist of factors for those seeking mpox vaccination. Includes a vaccination location finder.
These guidelines from the CDC outline the data requested from health departments in reporting mpox cases.
To prevent the spread to others when staying at home (isolating), people with mpox should follow the guidance in this CDC resource until the mpox rash has healed and a new layer of skin has formed.